According to the American Society of Clinical Oncology, around 2.4lac adults in the United States will be diagnosed with lung cancer of which 81% are NSCLC. Early diagnosis and treatment is one of the best indicators for lung cancer survival. A non randomized clinical trial has been published in JAMA Network Open has revealed that